Discover Thomson Reuters
Shares of Biogen soared as much as 23 percent Friday to a six-month high after the biotech company announced success in a mid-stage trial for drug to treat Alzheimer's.
01:14
02:28
00:46
01:41
00:44
01:02
01:50
00:28
01:59
01:36
02:25
01:47
02:36
02:21
02:10
01:17
00:51
03:08
01:21
01:45